Knight Therapeutics Inc T.GUD

Alternate Symbol(s): KHTRF

Healthcare

Knight Therapeutics Inc. is a Canada-based specialty pharmaceutical company. The Company's principal business activity includes developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invested in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The Company's portfolio consists of pharmaceutical products with molecules and includes both in-licensed products, such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome as well as products owned (or partially owned) by it, such as Exelon and Impavido.

TSX:GUD - Post by User

Knight Therapeutics Inc > Strong volume - big interest early m

<< Previous

Bullboard Posts

Next >>

Comment by porksnifferon Mar 03, 2021 3:01pm

92 Views

Post# 32707050

RE:RE:RE:RE:Strong volume - big interest early m

EbbFlow88 wrote: I calculated cash and equivalents at around $3/share. So, you're getting GBT at $2. There is definitely weakness in currency exchange but I agree regarding value. Just will need to be patient with this one. At this price though, it's a great bet.

Reading this is dam insulting. People have been in this piece of garbage for 6 years and have been decimated. I tip my hat to the CEO and our management for turning this debacle into the worse performing company in the country the past 1, 3, 5 years. Again, people need to appreciate how difficult it is to be the worst at anything....

<< Previous

Bullboard Posts

Next >>

Advancing an underexplored area of the Yukon with the same geology as B.C’.s Golden Triangle